Your browser doesn't support javascript.
loading
Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L.
LaFargue, Christopher J; Amero, Paola; Noh, Kyunghee; Mangala, Lingegowda S; Wen, Yunfei; Bayraktar, Emine; Umamaheswaran, Sujanitha; Stur, Elaine; Dasari, Santosh K; Ivan, Cristina; Pradeep, Sunila; Yoo, Wonbeak; Lu, Chunhua; Jennings, Nicholas B; Vathipadiekal, Vinod; Hu, Wei; Chelariu-Raicu, Anca; Ku, Zhiqiang; Deng, Hui; Xiong, Wei; Choi, Hyun-Jin; Hu, Min; Kiyama, Takae; Mao, Chai-An; Ali-Fehmi, Rouba; Birrer, Michael J; Liu, Jinsong; Zhang, Ningyan; Lopez-Berestein, Gabriel; de Franciscis, Vittorio; An, Zhiqiang; Sood, Anil K.
Afiliação
  • LaFargue CJ; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
  • Amero P; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Noh K; Istituto di Endocrinologia ed Oncologia Sperimentale, CNR, Naples, Italy.
  • Mangala LS; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
  • Wen Y; Laboratory of Disease Modeling and Therapeutics, Korea Research Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea.
  • Bayraktar E; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
  • Umamaheswaran S; Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Stur E; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA. ywen2@mdanderson.org.
  • Dasari SK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
  • Ivan C; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
  • Pradeep S; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
  • Yoo W; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
  • Lu C; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Jennings NB; Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
  • Vathipadiekal V; Department of Molecular & Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • Hu W; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
  • Chelariu-Raicu A; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
  • Ku Z; Wave Life Sciences, 733 Concord Avenue, Cambridge, MA, 02138, USA.
  • Deng H; Department of Genetic Medicines, Alloy Therapeutics, Waltham, USA.
  • Xiong W; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
  • Choi HJ; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, 77030, USA.
  • Hu M; Department of Obstetrics and Gynecology, Ludwig Maximilians University of Munich, Munich, Germany.
  • Kiyama T; German Cancer Consortium (DKTK), German Cancer Research Center, Munich, Germany.
  • Mao CA; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
  • Ali-Fehmi R; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
  • Birrer MJ; Texas Therapeutics Institute, Brown Foundation Institute of Molecular Medicine, The University of Texas Health Science Center at Houston, Houston, TX, 77030, USA.
  • Liu J; Department of Obstetrics and Gynecology, Chung-Ang University, College of Medicine, Seoul, Republic of Korea.
  • Zhang N; Department of Obstetrics and Gynecology, Chung-Ang University Gwangmyeong Hospital, College of Medicine Chung-Ang University, Seoul, South Korea.
  • Lopez-Berestein G; CPRIT Single Core, Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
  • de Franciscis V; Ruiz Department of Ophthalmology and Visual Science, McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, 77030, USA.
  • An Z; Ruiz Department of Ophthalmology and Visual Science, McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), Houston, TX, 77030, USA.
  • Sood AK; The MD Anderson Cancer Center/UTHealth Graduate School of Biomedical Sciences, Houston, TX, 77030, USA.
Nat Commun ; 14(1): 2407, 2023 04 26.
Article em En | MEDLINE | ID: mdl-37100807
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator A de Crescimento do Endotélio Vascular / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fator A de Crescimento do Endotélio Vascular / Neoplasias Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos